Literature DB >> 25725801

In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

Stéphanie O Morin1, Valentin Giroux, Cédric Favre, Yassina Bechah, Nathalie Auphan-Anezin, Romain Roncagalli, Jean-Louis Mège, Daniel Olive, Marie Malissen, Jacques A Nunès.   

Abstract

The CD28 costimulatory receptor has a pivotal role in T cell biology as this molecule amplifies T cell receptor (TCR) signals to provide an efficient immune T cell response. There is a large debate about how CD28 mediates these signals. Here, we designed a CD28 gene-targeted knock-in mouse strain lacking the cytoplasmic tail of CD28. As is the case in CD28-deficient (CD28 knock-out) mice, regulatory T cell homeostasis and T cell activation are altered in these CD28 knock-in mice. Unexpectedly, the presence of a CD28 molecule deprived of its cytoplasmic tail could partially induce some early activation events in T cells such as signaling events or expression of early activation markers. These results unravel a new mechanism of T cell costimulation by CD28, independent of its cytoplasmic tail.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25725801      PMCID: PMC4826669          DOI: 10.1007/s00018-015-1873-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  27 in total

1.  CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer.

Authors:  Fabien Garçon; Daniel T Patton; Juliet L Emery; Emilio Hirsch; Robert Rottapel; Takehiko Sasaki; Klaus Okkenhaug
Journal:  Blood       Date:  2007-11-15       Impact factor: 22.113

2.  Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL.

Authors:  J S Burr; N D Savage; G E Messah; S L Kimzey; A S Shaw; R H Arch; J M Green
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

3.  Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation.

Authors:  M F Bachmann; K McKall-Faienza; R Schmits; D Bouchard; J Beach; D E Speiser; T W Mak; P S Ohashi
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

4.  Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling.

Authors:  F Pagès; M Ragueneau; R Rottapel; A Truneh; J Nunes; J Imbert; D Olive
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

Review 5.  The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation.

Authors:  James L Riley; Carl H June
Journal:  Blood       Date:  2004-09-07       Impact factor: 22.113

6.  Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation.

Authors:  Lindzy F Dodson; Jonathan S Boomer; Christine M Deppong; Dulari D Shah; Julia Sim; Traci L Bricker; John H Russell; Jonathan M Green
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

7.  Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor.

Authors:  Yann M Kerdiles; Daniel R Beisner; Roberto Tinoco; Anne S Dejean; Diego H Castrillon; Ronald A DePinho; Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-01-11       Impact factor: 25.606

8.  Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation.

Authors:  Rémi Lasserre; Xiao-Jun Guo; Fabien Conchonaud; Yannick Hamon; Omar Hawchar; Anne-Marie Bernard; Saïdi M'Homa Soudja; Pierre-François Lenne; Hervé Rigneault; Daniel Olive; Georges Bismuth; Jacques A Nunès; Bernard Payrastre; Didier Marguet; Hai-Tao He
Journal:  Nat Chem Biol       Date:  2008-07-20       Impact factor: 15.040

9.  A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant.

Authors:  Lindzy D Friend; Dulari D Shah; Christine Deppong; Joseph Lin; Traci L Bricker; Twyla I Juehne; Christine M Rose; Jonathan M Green
Journal:  J Exp Med       Date:  2006-08-14       Impact factor: 14.307

10.  Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis.

Authors:  Soraya Meghari; Yassina Bechah; Christian Capo; Hubert Lepidi; Didier Raoult; Peter J Murray; Jean-Louis Mege
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  5 in total

1.  CD28 costimulation promotes an antitumor CD8+ T cell response in myeloid antigen-presenting cell niches.

Authors:  Jacques A Nunès; Daniel Olive
Journal:  Cell Mol Immunol       Date:  2021-12-15       Impact factor: 11.530

Review 2.  The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma.

Authors:  Daniel Feinberg; Barry Paul; Yubin Kang
Journal:  Cell Immunol       Date:  2019-08-13       Impact factor: 4.868

Review 3.  Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy.

Authors:  Stefan Stoiber; Bruno L Cadilha; Mohamed-Reda Benmebarek; Stefanie Lesch; Stefan Endres; Sebastian Kobold
Journal:  Cells       Date:  2019-05-17       Impact factor: 6.600

4.  Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line.

Authors:  Chung Hyo Kang; Yeongrin Kim; Heung Kyoung Lee; So Myoung Lee; Hye Gwang Jeong; Sang Un Choi; Chi Hoon Park
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

Review 5.  Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight.

Authors:  Craig A Land; Phillip R Musich; Dalia Haydar; Giedre Krenciute; Qian Xie
Journal:  J Transl Med       Date:  2020-11-11       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.